Advertisement

Topics

CellAegis Devices, Inc. Company Profile

09:27 EDT 20th October 2018 | BioPortfolio

CellAegis Devices, Inc., based in Toronto, Canada, is poised for EU market introduction in parallel with a broad international clinical testing program of the Company’s proprietary, automated, noninvasive autoRIC™ Device for Remote Ischemic Conditioning (RIC). Placed around the arm, CellAegis’ autoRIC Device allows for the first time, simple, consistent, reliable and cost-effective automation of RIC at the point of care, including acute care applications in the ambulance, emergency room and other hospital settings, or for chronic treatment in the home. The autoRIC Device is highly portable and time-efficient, delivering four cycles of simple-to-administer treatment in less than 40 minutes. The device is compatible with current standard-of-care treatments.


News Articles [440 Associated News Articles listed on BioPortfolio]

CellAegis Announces First Distribution Agreement for autoRIC® in Europe

TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis") a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective s...

CellAegis Announces Completion of Patient Enrollment in UK Investigator Sponsored Clinical Trial using autoRIC® Device

TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis" or the "Company"), a commercial-stage medical device company advancing innovative, n...

CellAegis Strengthens Management Team to Support Future Growth

TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis" or the "Company"), a commercial-stage medical device company advancing innovative, ...

CellAegis Announces Completion of Patient Enrollment in Danish Investigator Sponsored Clinical Trial Using autoRIC® Device

TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis" or the "Company"), a commercial-stage medical device company advancing innovative, non-invasive,...

CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial

TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis" or the "Company"), a commercial-stage medical device company advancing innovative, non...

Plug-and-play diagnostic devices

(Massachusetts Institute of Technology) Researchers at MIT's Little Devices Lab have developed modular blocks that can be put together in different ways to produce diagnostic devices. These 'plug-and-...

Mechanical Colonoscopy Detection Devices Better Than Wide-Angle Viewing

For improving mucosal exposure, mechanical devices outperformed optical devices in a meta-analysis.

[Health Policy] The need for transparency of clinical evidence for medical devices in Europe

To use medical devices rationally, health-care professionals must base their choices of which devices to recommend for individual patients on an objective appraisal of their safety and clinical effica...

PubMed Articles [722 Associated PubMed Articles listed on BioPortfolio]

Cardiac rhythm management devices

The last decade has seen ongoing evolution and use of cardiac rhythm management devices, including pacemakers, cardiac resynchronisation therapy, implantable cardioverter defibrillators and loop recor...

The regulatory ancestral network of surgical meshes.

All surgical meshes entering the U.S. market have been cleared for clinical use by the 510(k) process of the Food and Drug Administration (FDA), in which devices simply require proof of "substantial e...

Cecal Resection with Bipolar Sealing Devices in a Rat Model.

Bipolar sealing devices are routinely used to seal blood vessels. The aim of the study is to evaluate the feasibility and safety of colonic sealing with the use of the bipolar energy devices in rats a...

Patch Pumps for Insulin.

Newly developed patch pumps are starting to occupy a noticeable fraction of the insulin delivery market. New entrants, using novel technologies, promise accurate, flexible insulin delivery at lower co...

Percutaneous Lead Extraction in Infection of Cardiac Implantable Electronic Devices: a Systematic Review.

In the last two decades, the increased number of implants of cardiac implantable electronic devices has been accompanied by an increase in complications, especially infection. Current recommendations ...

Clinical Trials [1069 Associated Clinical Trials listed on BioPortfolio]

A Study of the Feasibility of Prehospital Remote Ischemic Conditioning

Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning (RIC) by emergency medical services (EMS) in the prehospital settin...

Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Healthy Volunteers

Parameters, sequences or paradigms optimisation in view of data quality and relevancy improvement.

Transvenous Lead Removal Post-Market Clinical Study

This prospective, multicenter, post-market clinical study was designed to evaluate the outcomes of lead extraction of cardiovascular implantable electronic devices (CIED) using Cook cathet...

Field Implementation of the autoRIC Device in STEMI

This is a "before and after" observational study of a therapeutic strategy to treat patients with confirmed ST-segment myocardial infarction (STEMI) with remote ischemic conditioning (RIC)...

Glottic View Using Supraglottic Devices in Pediatric Patients

Endotracheal intubation is the gold standard for securing the airway. However, while managing patients with difficult airways, various supraglottic devices have been used as rescue airway ...

Companies [1027 Associated Companies listed on BioPortfolio]

CellAegis Devices, Inc.

CellAegis Devices, Inc., based in Toronto, Canada, is poised for EU market introduction in parallel with a broad international clinical testing program of the Company’s propr...

Evergreen Medical Technologies

Evergreen Medical Technologies designs, manufactures and tests Class II and Class III medical devices for entrepreneurs, startups and established companies worldwide. Evergreen ha...

Analog Devices, Inc.

Innovation, performance, and excellence are the cultural pillars on which Analog Devices has built one of the longest standing, highest growth companies within the technology sect...

Symphonix Devices Incorporated

Hearing Devices.

Patton Medical Devices

Headquartered in Austin, Texas, Patton Medical Devices is the manufacturer of the i-port(R) Injection Port. For people taking injections who want to minimize the intrusion of injections on daily life,...

More Information about "CellAegis Devices, Inc." on BioPortfolio

We have published hundreds of CellAegis Devices, Inc. news stories on BioPortfolio along with dozens of CellAegis Devices, Inc. Clinical Trials and PubMed Articles about CellAegis Devices, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CellAegis Devices, Inc. Companies in our database. You can also find out about relevant CellAegis Devices, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record